Tetrasodium pyrophosphate

What this is

Tetrasodium pyrophosphate is one member of the larger phosphate additive group. It can act as a sequestrant, pH-control agent, emulsifying salt, stabilizer, thickener, humectant, or raising agent, depending on the food. U.S. FDA lists sodium pyrophosphate/tetrasodium pyrophosphate as GRAS when used under good manufacturing practice, while Codex, Canada, and the EU permit it within defined uses, food-category limits, or purity specifications. The safety concern is mainly cumulative phosphorus exposure rather than a specific tetrasodium-pyrophosphate cancer or genotoxicity signal. EFSA set a group acceptable daily intake for phosphates expressed as phosphorus and concluded that total dietary exposure may exceed that level for some children and high consumers; it also noted that the intake guidance does not apply to people with moderate to severe kidney-function reduction. Reviews in nephrology and nutrition literature emphasize that inorganic phosphate additives are more readily absorbed than many naturally bound food phosphates and are most relevant for people with chronic kidney disease or very high processed-food phosphate exposure. For most consumers, the concern is limited and exposure-related rather than a proven harm from occasional permitted food use.

Safety Review

The health areas reviewed when evaluating an ingredient. This does not mean the ingredient is proven to cause harm.

Tetrasodium pyrophosphate contributes inorganic phosphate, an essential nutrient that becomes a concern when total phosphorus intake is high or kidney function is reduced. EFSA set a group intake level for phosphate additives and found that total dietary exposure could exceed it for some children and high consumers; it also excluded people with moderate to severe kidney-function reduction from that guidance because high phosphate intake is a recognized kidney-related concern. Reviews link high serum phosphate and readily absorbed phosphate additives to mineral-balance, vascular, and cardiovascular concerns, especially in chronic kidney disease, but prospective controlled trials proving harm from ordinary food-label uses are limited. No broad current food ban was verified; the higher concern is exposure-related and subgroup-specific.

No additional safety information is available for this ingredient yet.